C12N 15/8676
Special methods for targeting systems
Official title: {Special methods for targeting systems}
C12N15/8676 (Special methods for targeting systems) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 6
- Assignees
- 3
- Inventors
- 11
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Methods and constructs for production of lentiviral vector19 Aug 2025US 12,391,960 B2Lonza Walkersville, Inc.
- Methods and constructs for production of lentiviral vector16 Jul 2024US 12,037,599 B2Lonza Walkersville, Inc.
- Modulation of liver genes30 Mar 2021US 10,960,085 B2Sangamo Therapeutics, Inc.
- Method for gene transfer23 Sep 2014US 8,841,126 B2Takara Bio Inc.
- Methods and constructs for production of lentiviral vector21 Aug 2025US 2025/0263749 A1Lonza Walkersville, Inc.
- Methods and constructs for production of lentiviral vector10 Oct 2024US 2024/0336936 A1Lonza Walkersville, Inc.
- Modulation of liver genes4 Mar 2021US 2021/0060179 A1Sangamo Therapeutics, Inc.
- Methods and constructs for production of lentiviral vector4 Mar 2021US 2021/0062220 A1Lonza Walkersville, Inc.
- Modulation of liver genes8 Mar 2018US 2018/0064827 A1Sangamo Therapeutics, Inc.
Most cited
By later US patents